• Reactifargan 2% cream 20g
1 1

Johnson & Johnson

Reactifargan 2% cream 20g

Reactifargan 2% cream 20g

€13,45
€14,46 €13,45
Sale Sold out
VAT included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

20g

EAN

002516060

MINSAN

002516060

View full details

In compliance with article 118 "authorization of advertising to the public" of the legislative decree of 24 April 2006, number 219

INDICATIONS

Local symptomatic treatment for insect bites and other localized skin irritation phenomena such as redness, burning, itching and sunburn.

CONTRAINDICATIONS

Hypersensitivity to the active substance or to any of the excipients. Eczema Secreting lesions. Children under 2 years of age.

WARNINGS AND PRECAUTIONS FOR USE

Prolonged and inappropriate use of the product can give rise to allergic sensitization phenomena with consequent worsening of symptoms. If this occurs, treatment should be suspended and the situation reassessed. If applied to very large areas of the skin REACTIFARGAN may cause drowsiness (see section 4.7). Given that the application of REACTIFARGAN can delay the healing process, it must not be used more than 3-4 consecutive days on lesions in which this phenomenon is taking place. In the case of sunburn, apply the product and avoid further exposure of the irritated skin to the sun. If skin rashes, irritation and burning phenomena occur, treatment should be suspended. Important information about some excipients REACTIFARGAN contains methyl p-hydroxybenzoate e propyl p-hydroxybenzoate which can cause allergic reactions (even delayed). REACTIFARGAN contains lavender oil, a fragrance which in turn contains D-Limonene, geraniol and linalool which can cause allergic reactions; REACTIFARGAN contains octyl methoxycinnamate which in turn contains butylated hydroxytoluene which may cause localized skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes.

INTERACTIONS

Not known.

SIDE EFFECTS

The side effects reported below arise from post-marketing and have an unknown frequency (the frequency cannot be established from the available data).

Classification by organs and systems | Frequency not known

Skin and subcutaneous tissue disorders | Dermatitis edema erythema bullous lesions photosensitivity

Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse

OUR PRODUCTS FOR THIS SEASON

1 10
View all
1 4

Responsibility for content
This sheet contains information that is not intended to replace a diagnosis or medical advice, as only a doctor can write any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note
The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they could be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the published information.

Data source: Farmadati Italia
Website: www.farmadati.it

The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalists, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory.

The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.